Skip to content

Prospective Analysis of Incidence and Risk Factors of Infection of Midline Catheter

Prospective Analysis of Incidence and Risk Factors of Infection of Midline Catheter

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03373630
Acronym
TIM-GHM
Enrollment
250
Registered
2017-12-14
Start date
2018-01-16
Completion date
2019-10-21
Last updated
2019-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravascular Device

Brief summary

The Midline catheter is a peripherally-inserted catheter, with the distal tip being placed at or below the level of the axilla. It is a relevant alternative to other catheters in case of limited venous access and long-run perfusions. Moreover, another significant advantage may be the reduction of the risk of infection. However, the Midline catheter is poorly described in scientific literature, essentially through retrospective and meta analyses including multiple types of catheters (Piccline, CVC, PAC). Therefore, the TIM-GHM study aims to prospectively assess the rate of infections in case of the Midline catheter. The results of this study could bring a collective benefit in terms of knowledge and reliability of these intravascular devices. Depending on these results, a randomized, controlled study will be considered, in order to compare the Midline catheter to its main alternative : the Piccline.

Interventions

DEVICEMidline catheter

The catheter will be inserted according to usual practices, after the enrollment of the patient in the study. The follow-up will last until the removal of the catheter, which will also be done according to usual practices. Following the removal, bacteriologic analyses will be performed in order to diagnose any prospective infection.

Sponsors

TIMC-IMAG
CollaboratorOTHER
Vygon GmbH & Co. KG
CollaboratorINDUSTRY
Groupe Hospitalier Mutualiste de Grenoble
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age superior or equal to 18 years old * Intravascular treatment planned for more than 6 days

Exclusion criteria

* Medical history of mastectomy with bilateral lymphadenectomy * Peripheral neuropathy * Upper-Extremity Deep Vein Thrombosis * Arteriovenous fistula * Poor condition of the skin of the upper limbs * Patient in palliative care * Patient in emergency care * Patient under guardianship/curatorship * Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frameDescription
Incidence of infection of midline catheterCatheter removal, performed up to 28 days after enrollmentThe method used for bacteriologic analyses will be the Brun Buisson Technique. The diagnosis of infection of the catheter will be based on the clinical signs, the catheter bacteriology, the blood culture collected on the patient and the blood culture collected on the catheter.

Secondary

MeasureTime frameDescription
Identification of intravenous treatments - CorticosteroidEveryday from baseline, up to 28 daysDetermination of whether corticosteroid are intravenously administered during the day (YES/NO).
Identification of intravenous treatments - AntibioticsEveryday from baseline, up to 28 daysDetermination of whether antibiotics are intravenously administered during the day (YES/NO).
Identification of intravenous treatments - ChemotherapyEveryday from baseline, up to 28 daysDetermination of whether chemotherapy was intravenously administered during the day (YES/NO).
Identification of intravenous treatments - Nutrient solutionEveryday from baseline, up to 28 daysDetermination of whether nutrient solution was intravenously administered during the day (YES/NO).
Duration of insertion procedureBaseline
Identification of the germs responsible for infections of midline catheterCatheter removal, performed up to 28 days after enrollmentFor each infected catheter, the species name of the germ responsible for the infection will be collected.
Body Mass IndexBaseline
White blood cells countEveryday from baseline, up to 28 days
Incidence of thrombosisCatheter removal, performed up to 28 days after enrollmentIf the catheter is no more permeable, a doppler echocardiography will be done to confirm the diagnosis of thrombosis.
Patient comfortEvery three days from baseline, up to 28 daysNumeric rating scale will be collected for each of these 3 dimensions : comfort when eating, comfort when moving, comfort for personal hygiene The scale will range from 0 to 10. 0 will mean very uncomfortable and 10 will mean very comfortable.
Lifetime of catheterCatheter removal, performed up to 28 days after enrollmentTime from catheter insertion to catheter removal, measured in days.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026